The authors apologize for an error in the above stated paper. In the body of the paper, it is stated that “ECMO was used 44 times (20 (27%) in those with 22q11 deletion, 24 (22%) in those without) (p=0.45)”. This is also indicated in Table 2. This data is incorrect and was due to a database error. After extensive chart review, there were only 12 instances of ECMO use identified over the eight-year time period of the study. Seven (6.5%) of these occurred in patients with normal genotype and five (6.8%) in patients with 22q11 deletion. There was no significant difference between the two groups. The use of postoperative ECMO was much lower than reported in the manuscript.
Article contents
Deletion of 22q11 chromosome is associated with postoperative morbidity after unifocalisation surgery – CORRIGENDUM
Published online by Cambridge University Press: 29 October 2018
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
- Type
- Corrigendum
- Information
- Copyright
- © Cambridge University Press 2018
Footnotes
Cite this article: Koth A, Sidell D, Bauser-Heaton H, Wise-Faberowski L, Hanley FL, McElhinney DB, Asija R. (2018) Deletion of 22q11 chromosome is associated with postoperative morbidity after unifocalisation surgery – CORRIGENDUM. Cardiology in the Young29: 23. doi: 10.1017/S1047951118001804
References
Koth, A, Sidell, D, Bauser-Heaton, H, Wise-Faberowski, L, Hanley, FL, McElhinney, DB, Asija, R. Deletion of 22q11 chromosome is associated with postoperative morbidity after unifocalisation surgery. Cardiol Young. Published by Cambridge University Press, 30 August 2018. doi: 10.1017/S1047951118001427
Google Scholar
This correction applies to the following article(s):
You have
Access
- 1
- Cited by